Eli Lilly listed as top biopharmaceutical employer

Eli Lilly has announced it has made the list of top 20 biopharmaceutical employers in the peer-reviewed journal Science.

The company ranked in at number ten on the list, noting this is one position up from where it stood in the previous year’s survey.

Steven Paul, managing director and executive vice-president of science and technology at the company, states Lilly’s mission is to deliver innovative medicines for some of the world’s most urgent and unmet medical needs.

“Core to our pipeline performance is the robust research environment here at Lilly, including excellence in both basic scientific and clinical research.

“Our world-renowned scientific talent has allowed Lilly to establish what we believe to be one of the best mid-stage pipelines in the industry,” he adds.

John Lechleiter, chief executive officer and president of the company, adds it is an honour for the firm to be recognised as one of the sector’s top employers by the publication.

In recent days, Lilly announced it will announce its fiscal results for the third quarter of 2008 on Thursday October 23rd, 2008.